Fishman Jay A Ltd. MI Sells 2,415 Shares of Danaher Corporation (NYSE:DHR)

Fishman Jay A Ltd. MI cut its holdings in shares of Danaher Corporation (NYSE:DHR - Free Report) by 17.0% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 11,766 shares of the conglomerate's stock after selling 2,415 shares during the period. Fishman Jay A Ltd. MI's holdings in Danaher were worth $2,412,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently made changes to their positions in DHR. LaFleur & Godfrey LLC boosted its stake in Danaher by 1.5% in the fourth quarter. LaFleur & Godfrey LLC now owns 29,855 shares of the conglomerate's stock valued at $6,853,000 after acquiring an additional 440 shares during the last quarter. Union Bancaire Privee UBP SA bought a new position in shares of Danaher in the 4th quarter worth $74,551,000. Bank Pictet & Cie Europe AG increased its holdings in shares of Danaher by 22.8% in the 4th quarter. Bank Pictet & Cie Europe AG now owns 192,731 shares of the conglomerate's stock worth $44,241,000 after buying an additional 35,730 shares during the last quarter. Strategic Financial Concepts LLC purchased a new stake in shares of Danaher in the 4th quarter valued at $31,000. Finally, D.A. Davidson & CO. boosted its stake in shares of Danaher by 11.6% in the 4th quarter. D.A. Davidson & CO. now owns 14,835 shares of the conglomerate's stock valued at $3,405,000 after purchasing an additional 1,541 shares in the last quarter. 79.05% of the stock is owned by institutional investors.

Analyst Ratings Changes

DHR has been the subject of several research analyst reports. HSBC dropped their target price on shares of Danaher from $270.00 to $240.00 in a research report on Friday, April 25th. Bank of America dropped their target price on shares of Danaher from $265.00 to $230.00 in a research report on Monday, April 14th. Citigroup reaffirmed a "buy" rating on shares of Danaher in a research report on Monday, April 7th. Wells Fargo & Company dropped their target price on shares of Danaher from $240.00 to $210.00 and set an "equal weight" rating for the company in a research report on Wednesday, April 23rd. Finally, The Goldman Sachs Group decreased their price target on shares of Danaher from $260.00 to $240.00 and set a "neutral" rating for the company in a research note on Wednesday, April 23rd. Five equities research analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company. According to data from MarketBeat.com, Danaher presently has a consensus rating of "Moderate Buy" and an average target price of $248.17.

Insider Transactions at Danaher

In other Danaher news, Chairman Steven M. Rales sold 1,250,000 shares of the stock in a transaction dated Monday, May 12th. The shares were sold at an average price of $196.74, for a total transaction of $245,925,000.00. Following the transaction, the chairman now directly owns 3,105,808 shares in the company, valued at $611,036,665.92. This represents a 28.70% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Christopher Paul Riley sold 15,805 shares of the stock in a transaction dated Wednesday, April 30th. The shares were sold at an average price of $198.00, for a total transaction of $3,129,390.00. Following the sale, the executive vice president now directly owns 15,179 shares of the company's stock, valued at approximately $3,005,442. The trade was a 51.01% decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 11.10% of the company's stock.

Danaher Trading Up 0.9%

Shares of DHR opened at $196.23 on Friday. Danaher Corporation has a twelve month low of $171.00 and a twelve month high of $281.70. The company has a market cap of $140.43 billion, a P/E ratio of 38.10, a P/E/G ratio of 2.73 and a beta of 0.77. The company has a current ratio of 1.43, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31. The company's fifty day simple moving average is $193.89 and its 200-day simple moving average is $209.69.

Danaher (NYSE:DHR - Get Free Report) last posted its quarterly earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 EPS for the quarter, topping analysts' consensus estimates of $1.62 by $0.26. The firm had revenue of $5.74 billion for the quarter, compared to analysts' expectations of $5.58 billion. Danaher had a net margin of 15.81% and a return on equity of 10.80%. As a group, analysts expect that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, July 25th. Stockholders of record on Friday, June 27th will be issued a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.65%. Danaher's payout ratio is presently 24.85%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.